申请人:Peterson John Matthew
公开号:US20110230497A1
公开(公告)日:2011-09-22
The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from certain disorders which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, this invention also provides uses of a compound of the invention for the manufacture of a medicament for treating a subject suffering from certain disorders.
本发明涉及生物活性酰胺,其是NPY Y5受体的配体。该发明还提供了一种制药组合物,包括本发明化合物的治疗有效量和药学可接受载体。本发明还提供了治疗患有某些疾病的受试者的方法,包括向受试者投予本发明化合物的量。此外,本发明还提供了一种利用本发明化合物制造治疗患有某些疾病的受试者的药物的用途。